The biotechnology sector has been at the forefront of innovation. Over the past five years, the biotech industry grew at a CAGR of 7%, and by 2025, the biotech industry is expected to reach a valuation of $725 billion.
Given the industry’s steady growth prospects, investors could buy biotech stocks Protalix BioTherapeutics, Inc. (PLX), Organogenesis Holdings Inc. (ORGO), and ANI Pharmaceuticals, Inc. (ANIP) for monthly gains.
